| Entry |
|
|---|
| Name |
Nicotinic acid (JP16/INN);
Niacin (USP);
Niacor (TN);
Niaspan (TN)
|
|---|
| Product |
|
|---|
| Generic |
|
|---|
| Formula |
C6H5NO2
|
|---|
| Exact mass |
123.032
|
|---|
| Mol weight |
123.1094
|
|---|
| Structure |
     |
|---|
| Activity |
Antihyperlipidemic;
Vitamin [enzyme co-factor]
|
|---|
| Remark |
Same as: Therapeutic category: ATC code: |
|---|
| Interaction |
|
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
31 Vitamins
313 Vitamin B preparations
3132 Nicotinic acids
D00049 Nicotinic acid (JP16/INN); Niacin (USP)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C04 PERIPHERAL VASODILATORS
C04A PERIPHERAL VASODILATORS
C04AC Nicotinic acid and derivatives
C04AC01 Nicotinic acid
D00049 Nicotinic acid (JP16/INN); Niacin (USP)
C10 LIPID MODIFYING AGENTS
C10A LIPID MODIFYING AGENTS, PLAIN
C10AD Nicotinic acid and derivatives
C10AD02 Nicotinic acid
D00049 Nicotinic acid (JP16/INN); Niacin (USP)
USP drug classification [BR:br08302]
Cardiovascular Agents
Dyslipidemics, Other
Niacin
D00049 Nicotinic acid (JP16/INN); Niacin (USP)
 |
|---|
| Other DBs |
CAS: 59-67-6 PubChem: DrugBank: PDB-CCD: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 9
1 C8y C 25.1352 -16.9986
2 C8x C 23.9013 -16.3004
3 C8x C 25.1469 -18.3372
4 C6a C 26.3341 -16.2944
5 C8x C 22.6849 -17.0102
6 N5x N 23.9013 -19.1114
7 O6a O 27.5389 -16.9812
8 O6a O 26.3108 -14.9035
9 C8x C 22.6908 -18.4130
BOND 9
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 2
5 3 6 1
6 4 7 1
7 4 8 2
8 5 9 1
9 6 9 2
|
|---|
